Gilstrap L C, Hauth J C, Hankins G D, Patterson A R
Obstet Gynecol. 1987 Mar;69(3 Pt 1):328-32.
Halogenated anesthetic agents have been used to supplement nitrous oxide during balanced general anesthesia for cesarean delivery to decrease maternal awareness. However, these agents can interfere with uterine contractility and hence have the potential to increase blood loss at the time of cesarean section. To ascertain the effect of the addition of halogenated anesthetic agents for cesarean section anesthesia versus conduction or a simple balanced general anesthetic, we retrospectively assessed three aspects that may reflect operative blood loss at the time of cesarean section. Significantly more women whose balanced general anesthesia for cesarean section was supplemented with a halogenated agent (usually 0.5% halothane) versus those with a conduction or balanced general anesthetic required transfusion therapy, had a postpartum hematocrit less than 30 vol% and had a decrease in the pre- to postdelivery hematocrit of at least 8 vol %. The addition of halogenated anesthetic agents to a balanced nitrous oxide anesthesia for the purpose of decreased maternal awareness must be weighed against the risk incurred from the increased requirement for blood replacement and/or from postpartum anemia.
在剖宫产的平衡全身麻醉期间,卤化麻醉剂已被用于补充氧化亚氮,以降低产妇的知晓率。然而,这些药物会干扰子宫收缩力,因此有可能增加剖宫产时的失血量。为了确定在剖宫产麻醉中添加卤化麻醉剂与传导麻醉或单纯平衡全身麻醉相比的效果,我们回顾性评估了三个可能反映剖宫产时手术失血量的方面。与采用传导麻醉或平衡全身麻醉的女性相比,剖宫产平衡全身麻醉中补充卤化剂(通常为0.5%氟烷)的女性明显更多地需要输血治疗,产后血细胞比容低于30%,且分娩前后血细胞比容至少降低8%。为降低产妇知晓率而在平衡氧化亚氮麻醉中添加卤化麻醉剂时,必须权衡因增加输血需求和/或产后贫血而带来的风险。